Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma
source: pixabay.com

Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma

According to a story from BioSpace, the U.S. Food and Drug Administration has given Fast Track designation for nintedanib, which is undergoing testing for the treatment of systemic sclerosis with…

Continue Reading Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma
No-Cost Disease Diagnosis and Immunoglobulin Therapies Now Available to Children with Primary Immunodeficiency Diseases
Source: Pixabay

No-Cost Disease Diagnosis and Immunoglobulin Therapies Now Available to Children with Primary Immunodeficiency Diseases

Primary immunodeficiency diseases account for hundreds of rare and chronic diseases. In children, this may mean that their immune system is non-existent or doesn't perform as expected. To learn more…

Continue Reading No-Cost Disease Diagnosis and Immunoglobulin Therapies Now Available to Children with Primary Immunodeficiency Diseases
The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from raredr.com, The U.S. Food and Drug Administration (FDA) has recently approved Hizentra as a maintenance therapy for patients with chronic inflammatory demyelinating polyneuropathy. Hizentra is…

Continue Reading The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy
source: pixabay.com

The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy

According to a story from raredr.com, the FDA had to order the cessation of Phase II/III trials for the microdystrophin transfer therapy SGT-001, which was in development for the treatment…

Continue Reading The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy
Upcoming Right To Try Webinar
Source: Pixabay

Upcoming Right To Try Webinar

A “Right to Try” bill is currently being discussed by Congress. Advocates on both sides of the story present valid points to either pass or stop the bill. That’s why…

Continue Reading Upcoming Right To Try Webinar
New Study Explains Why Elephants Don’t Get Cancer and Could Lead to New Treatments For Humans
Source: Pixabay

New Study Explains Why Elephants Don’t Get Cancer and Could Lead to New Treatments For Humans

A team lead by geneticist Christopher Gregg from the University of Utah conducted a study on elephant genes that discovered why elephants don't get cancer, reported by News 4 Tucson.…

Continue Reading New Study Explains Why Elephants Don’t Get Cancer and Could Lead to New Treatments For Humans
This Disease is Considered a “Delusion” by The Medical Community. A New Study Says It’s Not.
source: pixabay.com

This Disease is Considered a “Delusion” by The Medical Community. A New Study Says It’s Not.

According to a story from BioPortfolio, a recent study claims the Morgellons disease, a condition that has been shrouded in confusion and controversy, is not a delusion as some prior…

Continue Reading This Disease is Considered a “Delusion” by The Medical Community. A New Study Says It’s Not.
UK Family Travels to The Netherlands To Find Treatment For Their Daughter With Dravet Syndrome
Source: Pixabay

UK Family Travels to The Netherlands To Find Treatment For Their Daughter With Dravet Syndrome

According to BelfastLive, Darren and Danielle Gibson, the parents of little six-year-old Sophia battling Dravet syndrome, traveled out of the country in search of the care she needs. For the…

Continue Reading UK Family Travels to The Netherlands To Find Treatment For Their Daughter With Dravet Syndrome
Copper Deficiency a Possible Culprit in Charcot-Marie-Tooth Disease
Source: Pixabay

Copper Deficiency a Possible Culprit in Charcot-Marie-Tooth Disease

According to a recent study, low copper levels could have a hand in leading to Charcot-Marie-Tooth disease, Charcot-Marie-Tooth News reports. Charcot-Marie-Tooth disease (CMT) is a neurological disorder that affects the…

Continue Reading Copper Deficiency a Possible Culprit in Charcot-Marie-Tooth Disease